NCT04994847View on ClinicalTrials.gov

APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease

Enrolling by invitationOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Alzheimer Disease

Interventions

DRUG

Amyloid and Tau PET

NAV4694 and MK6240 PET scans completed every two years

Trial Locations (1)

85006

Banner Alzheimer's Institute, Phoenix

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Mayo Clinic

OTHER

lead

Banner Health

OTHER